- Home
- CPIX vs MAIA Comparison
CPIX vs MAIA Comparison
Compare CPIX & MAIA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CPIX
- MAIA
- Stock Information
- Founded
- CPIX 1999
- MAIA 2018
- Country
- CPIX United States
- MAIA United States
- Employees
- CPIX N/A
- MAIA N/A
- Industry
- CPIX Biotechnology: Pharmaceutical Preparations
- MAIA Biotechnology: Pharmaceutical Preparations
- Sector
- CPIX Health Care
- MAIA Health Care
- Exchange
- CPIX Nasdaq
- MAIA Nasdaq
- Market Cap
- CPIX 40.1M
- MAIA 46.7M
- IPO Year
- CPIX 2009
- MAIA 2022
- Fundamental
- Price
- CPIX $3.15
- MAIA $1.82
- Analyst Decision
- CPIX
- MAIA
- Analyst Count
- CPIX 0
- MAIA 0
- Target Price
- CPIX N/A
- MAIA N/A
- AVG Volume (30 Days)
- CPIX 110.2K
- MAIA 549.7K
- Earning Date
- CPIX 08-05-2025
- MAIA 08-08-2025
- Dividend Yield
- CPIX N/A
- MAIA N/A
- EPS Growth
- CPIX N/A
- MAIA N/A
- EPS
- CPIX N/A
- MAIA N/A
- Revenue
- CPIX $41,083,299.00
- MAIA N/A
- Revenue This Year
- CPIX N/A
- MAIA N/A
- Revenue Next Year
- CPIX N/A
- MAIA N/A
- P/E Ratio
- CPIX N/A
- MAIA N/A
- Revenue Growth
- CPIX 5.82
- MAIA N/A
- 52 Week Low
- CPIX $1.04
- MAIA $1.40
- 52 Week High
- CPIX $7.25
- MAIA $4.24
- Technical
- Relative Strength Index (RSI)
- CPIX 37.09
- MAIA 53.36
- Support Level
- CPIX $2.52
- MAIA $1.60
- Resistance Level
- CPIX $3.76
- MAIA $2.03
- Average True Range (ATR)
- CPIX 0.59
- MAIA 0.12
- MACD
- CPIX -0.14
- MAIA 0.02
- Stochastic Oscillator
- CPIX 19.39
- MAIA 58.14
About CPIX Cumberland Pharmaceuticals Inc.
Cumberland Pharmaceuticals Inc is a specialty pharmaceutical company focused on the acquisition, development, and commercialization of branded prescription pharmaceutical products. The Company has one operating segment which is specialty pharmaceutical products. The company's target markets are hospital acute care, gastroenterology, rheumatology, and oncology. The company promotes its approved products through its hospital, field, and oncology sales divisions in the United States and establishes a network of international partners to register and provide medicines to patients in their countries. The company's revenue is derived from the product sales of FDA-approved pharmaceutical brands. Its brands include Acetadote, Caldolor, Kristalose, Omeclamox, Sancuso, Vaprisol and Vibativ.
About MAIA MAIA Biotechnology Inc.
MAIA Biotechnology Inc is a clinical-stage biopharmaceutical company developing targeted immunotherapies for cancer. THIO (6-thio-dG or 6-thio-2 '-deoxyguanosine), its lead asset, is an investigational dual mechanism of action drug candidate incorporating telomere targeting and immunogenicity. Patients with advanced NSCLC will be treated first with THIO followed a few days later by the immune checkpoint inhibitor Libtayo (cemiplimab), manufactured and commercialized by Regeneron.